47 related articles for article (PubMed ID: 22076761)
21. Synthesis and docking studies of novel antitumor benzimidazoles.
Omar MA; Shaker YM; Galal SA; Ali MM; Kerwin SM; Li J; Tokuda H; Ramadan RA; El Diwani HI
Bioorg Med Chem; 2012 Dec; 20(24):6989-7001. PubMed ID: 23123017
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antiproliferative activity in vitro of 2-aminobenzimidazole derivatives.
Nawrocka W; Sztuba B; Kowalska MW; Liszkiewicz H; Wietrzyk J; Nasulewicz A; Pełczyńska M; Opolski A
Farmaco; 2004 Feb; 59(2):83-91. PubMed ID: 14871499
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of novel 1H-1,2,3-triazole tethered C-5 substituted uracil-isatin conjugates and their cytotoxic evaluation.
Kumar K; Sagar S; Esau L; Kaur M; Kumar V
Eur J Med Chem; 2012 Dec; 58():153-9. PubMed ID: 23124212
[TBL] [Abstract][Full Text] [Related]
24. Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives.
Sondhi SM; Rani R; Singh J; Roy P; Agrawal SK; Saxena AK
Bioorg Med Chem Lett; 2010 Apr; 20(7):2306-10. PubMed ID: 20188544
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of novel 4-(1H-benzimidazol-2-yl)benzene-1,3-diols and their cytotoxic activity against human cancer cell lines.
Karpińka MM; Matysiak J; Niewiadomy A
Arch Pharm Res; 2011 Oct; 34(10):1639-47. PubMed ID: 22076764
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of novel isatin-thiazoline and isatin-benzimidazole conjugates as anti-breast cancer agents.
Taher AT; Khalil NA; Ahmed EM
Arch Pharm Res; 2011 Oct; 34(10):1615-21. PubMed ID: 22076761
[TBL] [Abstract][Full Text] [Related]
27. In-vitro Evaluation of Isatin Derivatives as Potent Anti-Breast Cancer Agents against MCF-7, MDA MB 231, MDA-MB 435 and MDA-MB 468 Breast Cancers Cell Lines: A Review.
Chauhan G; Pathak DP; Ali F; Dubey P; Khasimbi S
Anticancer Agents Med Chem; 2022; 22(10):1883-1896. PubMed ID: 34477529
[TBL] [Abstract][Full Text] [Related]
28. Isatin-azole hybrids and their anticancer activities.
Hou Y; Shang C; Wang H; Yun J
Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900272. PubMed ID: 31691360
[TBL] [Abstract][Full Text] [Related]
29. Isatin dimers and their biological activities.
Zhang YZ; Du HZ; Liu HL; He QS; Xu Z
Arch Pharm (Weinheim); 2020 Mar; 353(3):e1900299. PubMed ID: 31985855
[TBL] [Abstract][Full Text] [Related]
30. The anti-breast cancer potential of indole/isatin hybrids.
Wang R; Huang R; Yuan Y; Wang Z; Shen K
Arch Pharm (Weinheim); 2023 Nov; 356(11):e2300402. PubMed ID: 37650315
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and Anti-Cancer Applications of Benzimidazole Derivatives - Recent Studies.
Tyagi YK; Jali G; Singh R
Anticancer Agents Med Chem; 2022; 22(19):3280-3290. PubMed ID: 36221180
[TBL] [Abstract][Full Text] [Related]
32. Thiazolo[3,2-a]benzimidazoles: synthetic strategies, chemical transformations and biological activities.
Al-Rashood KA; Abdel-Aziz HA
Molecules; 2010 May; 15(6):3775-815. PubMed ID: 20657409
[TBL] [Abstract][Full Text] [Related]
33. Benzimidazole derivatives as potential anticancer agents.
El Rashedy AA; Aboul-Enein HY
Mini Rev Med Chem; 2013 Mar; 13(3):399-407. PubMed ID: 23190032
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]